Insider Cluster (3 insiders) ·Filed Mar 2, 2026

MDGL

MADRIGAL PHARMACEUTICALS, INC.
NEUTRAL
Impact 3/10
Horizondays Processed6mo ago
Insider cluster: 2 insiders, $717K total
Actionable Insight • Neutral

Monitor for additional insider selling or changes in trading plan disclosures; current activity is within normal ranges for a company of this size and does not signal material concern.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
MDGL ▲ +20.35% at T+60d
NEUTRAL call ✓ call won +20.35% · α vs SPY +11.03% · entry $435.62 → $524.28
Entry anchored
Feb 27, 03:59 PM ET
via exchange tick
T+1d
-2.24%
call -2.24% · α -1.33%
$425.85
settled 7mo ago
T+5d
-0.56%
call -0.56% · α +0.65%
$433.20
settled 7mo ago
T+20d
+16.00%
call +16.00% · α +23.94%
$505.34
settled 6mo ago
T+60d
+20.35%
call +20.35% · α +11.03%
$524.28
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Two Madrigal Pharmaceuticals insiders conducted open-market sales totaling $717K in the past week, including CFO Mardi Dier selling $505K of shares. A separate non-cash award of shares to the Chief Medical Officer does not represent economic activity. The sales amount to a small fraction of the company's $10.1B market cap and align with routine pre-arranged trading plans.

Key Financial Metrics

Direction
selling
Total Value
$717.5K
Insiders
3

Key Facts

  • CFO Mardi Dier sold 1,183 shares for $505,389 in an open-market transaction.
  • Director Rebecca Taub sold 491 shares for $212,083, also in an open-market sale.
  • Chief Medical Officer David Soergel was granted 4,374 shares at $0 value — a non-cash equity award.
  • Total open-market sale value: $717,479.
  • Cluster represents approximately 0.007% of the company's $10.1B market cap.

Financial Impact

$717K in net insider selling over 7 days

insider ownershipmarket sentiment

Risk Factors

  • Perception risk if selling continues or accelerates ahead of key events like earnings or regulatory decisions.
  • Concentration risk in executive decision-making given limited number of active insiders trading.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (3 trades, 7d window)cluster-MDGL-1772838475323
9 reports for MDGL
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for MDGL — sortable, filterable
TypeNow
Aug 12, 2026
7w ago
8-K
NEUTRAL ★ 3/10
$536.20 $533.12▼ −0.57%▲ +1.32%$496.64 (−7.38%)
Jul 30, 2026
9w ago
8-K
BULLISH ★ 7/10
$493.11 $543.69▲ +10.26%▲ +6.29%$496.64 (+0.71%)
May 22, 2026
18w ago
Insider Cluster
NEUTRAL ★ 3/10
$524.28 $520.00▼ −0.82%▲ +1.13%$496.64 (−5.27%)
May 6, 2026
21w ago
8-K
BULLISH ★ 7/10
$539.73 $488.15▼ −9.56%▼ −12.34%$496.64 (−7.98%)
Apr 28, 2026
22w ago
8-K
NEUTRAL ★ 2/10
$518.58 $515.96▼ −0.51%▼ −6.55%$496.64 (−4.23%)
Apr 22, 2026
23w ago
Press Release
NEUTRAL ★ 3/10
$529.14 $511.82▼ −3.27%▼ −6.44%$496.64 (−6.14%)
Mar 19, 2026
28w ago
Press Release
NEUTRAL ★ 3/10
$441.16 $527.11▲ +19.48%▲ +10.16%$496.64 (+12.57%)
Mar 2, 2026
30w ago
Insider Cluster
NEUTRAL ★ 4/10
$435.62 $505.34▲ +16.00%▲ +23.94%$496.64 (+14.01%)
Mar 2, 2026
30w ago
Insider Cluster
NEUTRAL ★ 3/10
$435.62 $505.34▲ +16.00%▲ +23.94%$496.64 (+14.01%)
Showing 9 of 9

US Market Status

Market Open — Closes in 52m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Mar 6, 2026